首页> 外文期刊>Journal of thrombosis and thrombolysis >Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.
【24h】

Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.

机译:下肢局部缺血的局部动脉内溶栓治疗期间出血的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Assessment of clinical risk factors for haemorrhagic complications in patients undergoing intra-arterial thrombolysis for lower limb ischaemia. Retrospective reviews of consecutive patients subjected to intra-arterial thrombolysis due to lower limb ischemia at the Vascular Center, Malmo University Hospital, during a 5-year period from 2001 to 2005. Two hundred and twenty intra-arterial thrombolytic procedures were carried out in 195 patients (46% women), median age 73 years. Haemorrhagic complications were recorded in 72 procedures (33%), of which 13 were discontinued. Haemorrhage at the introducer and distant sites occurred in 53 and 32 procedures, respectively. Thrombolysis for occluded synthetic grafts was associated with higher risk of haemorrhage (P = 0.043). The platelet count was lower (P = 0.017) and the dose of alteplas higher (P = 0.041) in bleeders than in non-bleeders. Age was not associated with haemorrhage (P = 0.30). Two patients died during thrombolysis, one of them due to intracerebral haemorrhage. The grade of thrombolysis was an independent predictor of both in-hospital amputation (P < 0.001; OR 3.5 [95% CI 2.1-5.8]) and mortality (P = 0.021; OR 3.0 [95% CI 1.2-7.9]). The in-hospital amputation-free survival rate was 85% (188/220). Haemorrhage associated with thrombolysis is common, but does seldom require discontinuation of treatment. Insertion of introducers for local thrombolysis through synthetic grafts, lower platelet count and higher alteplas dose were found to be risk factors for haemorrhage. An algorithm for clinical management of haemorrhage has been proposed.
机译:评估接受动脉内溶栓治疗下肢缺血的患者出血并发症的临床危险因素。在2001年至2005年的5年期间,对马尔摩大学医院血管中心因下肢缺血而连续发生动脉内溶栓的患者进行回顾性回顾。195年进行了220次动脉内溶栓手术患者(女性占46%),中位年龄73岁。在72例手术中记录了出血并发症(33%),其中13例被中止。引入者和远端部位的出血分别发生在53和32处手术中。封堵的人造移植物的溶栓与出血的较高风险相关(P = 0.043)。与非出血者相比,出血者的血小板计数更低(P = 0.017),阿替普拉斯的剂量更高(P = 0.041)。年龄与出血无关(P = 0.30)。两名患者在溶栓过程中死亡,其中一名因脑出血而死亡。溶栓程度是院内截肢(P <0.001; OR 3.5 [95%CI 2.1-5.8])和死亡率(P = 0.021; OR 3.0 [95%CI 1.2-7.9])的独立预测指标。院内无截肢生存率为85%(188/220)。与溶栓相关的出血很常见,但很少需要中断治疗。通过合成移植物插入局部溶栓的导尿管,降低血小板计数和增加阿特普拉斯剂量是出血的危险因素。已经提出了一种用于临床管理出血的算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号